Почетна › Метастатски карцином › Kentaki › Lexington

Kliničke studije za Метастатски карцином u gradu Lexington, KY

10 studija za Метастатски карцином traži učesnike na lokacijama u gradu Lexington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Тражи се учесникФаза 2

CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
University of Kentucky/Markey Cancer Center, Lexington

Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Тражи се учесникФаза 1

University of Kentucky/Markey Cancer Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05372614

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Тражи се учесникФаза 3

Baptist Health Lexington, Lexington
University of Kentucky Chandler Medical Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3

University of Kentucky Chandler Medical Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Тражи се учесникФаза 2/3

University of Kentucky Markey Cancer Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Тражи се учесникФаза 2

University of Kentucky/Markey Cancer Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06311214

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Тражи се учесникФаза 2/3

University of Kentucky Research Foundation, Lexington
University of Kentucky Healthcare - Markey Cancer Center, Lexington
University of Kentucky Medical Center, Lexington
и још 1

Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Тражи се учесникФаза 3

Baptist Health Lexington, Lexington
Baptist Health Richmond, Lexington
Baptist Health Hamburg, Lexington
и још 3

Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Тражи се учесникФаза 1

UK Markey Cancer Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 11. 6. 2026. · NCT05283330

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Тражи се учесникФаза 1

University of Kentucky Markey Cancer Center, Lexington

Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2026. · NCT06778863

Studije za Метастатски карцином u drugim gradovima

Ostale studije u gradu Lexington

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.